ISTA Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference

IRVINE, Calif., May 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Ninth Annual JMP Securities Research Conference at 2:30 pm Pacific Time on May 12, 2010, in San Francisco, CA. ISTA's Chief Financial Officer and Vice President of Corporate Development Lauren Silvernail will provide an update on the Company's marketed products and clinical programs.

The presentation will be webcast. To access the live audio broadcast of the presentation or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals, Inc., is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, allergy, glaucoma, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

SOURCE ISTA Pharmaceuticals, Inc.